GlassScriptPhysician profile
Brian C Bennett
NPI 1891766077
$11,172.16
in general payments reported to CMS, 2019-2025
49 companies · $1,620 in 2025
The $1,620 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $690 · 2021: $1,829 · 2022: $1,942 · 2023: $2,064 · 2024: $1,872 · 2025: $1,620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,555.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,486.96 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $1,752.60 | 2019-2025 | Erleada, Akeega, Abiraterone Acetate |
| Myriad Genetic Laboratories, INC. | $870.76 | 2020-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $827.21 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $741.94 | 2019-2025 | Xtandi |
| Merck Sharp & Dohme LLC | $371.76 | 2020-2025 | Lynparza, Welireg, Keytruda |
| Abbvie INC. | $363.57 | 2019-2025 | Botox |
| Blue Earth Diagnostics | $303.32 | 2019-2024 | |
| Urovant Sciences INC | $292.16 | 2021-2022 | |
| Antares Pharma, INC. | $276.54 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Urogen Pharma, INC. | $261.97 | 2021-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $255.63 | 2019-2023 | Xiaflex |
| Olympus America INC. | $243.68 | 2021-2025 | Itind System, Bovie, Oes Cystonephrofiberscope |
| Accord Healthcare, INC. | $238.32 | 2022 | |
| Pfizer INC. | $218.55 | 2019-2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.